Navigation

Published technology appraisals

This table lists published NICE technology appraisals. The list can be sorted by title (alphabetically), issue date and review date. You can also:

  • click the appraisal title for full details
  • click a column heading to sort the list by that column

Please note that the 'review date' is not the date when a review of it the appraisal starts, but the date NICE consults on a proposal for reviewing it. There is no guarantee that at the review date, a review will be undertaken. Appraisals which have been considered for review and where the decision has been not to carry out a review at this time are listed in static technology appraisals.

More information on the published appraisals list.

For technology appraisal guidance organised by category, use Find guidance in the main header area above.

Searching for specific technology appraisal guidance?

Published appraisals

Results 1-20 of 308

Ref Title Date Issued Review
TA1 Wisdom teeth - removal (TA1) Mar 2000 TBC
TA2 Hip disease - replacement prostheses (TA2) (replaced by TA304) Apr 2000 May 2011
TA3 Ovarian cancer - taxanes (TA3) (replaced by TA55) (withdrawn) May 2000 TBC
TA4 Ischaemic heart disease - coronary artery stents (TA4) (replaced by TA71) (withdrawn) May 2000 TBC
TA5 Cervical cancer - liquid based cytology (TA5) (replaced by TA69) (withdrawn) Jun 2000 TBC
TA6 Breast cancer - taxanes (TA6) (replaced by TA30) (withdrawn) Jun 2000 TBC
TA7 Dyspepsia - proton pump inhibitors (TA7) (replaced by CG17) (withdrawn) Jul 2000 TBC
TA8 Hearing disability - hearing aids (withdrawn) (TA8) (withdrawn) Jul 2000 TBC
TA9 Diabetes (type 2) - rosiglitazone (TA9) (replaced by TA63) (withdrawn) Aug 2000 TBC
TA10 Asthma (children under 5) - inhaler devices (TA10) Aug 2000 TBC
TA11 Arrhythmias - implantable cardioverter defibrillators (ICDs) (TA11) (replaced by TA95) (withdrawn) Sep 2000 TBC
TA12 Acute coronary syndromes - glycoprotein IIb/IIIa inhibitors (TA12) (replaced by TA47) (withdrawn) Sep 2000 TBC
TA13 Attention deficit hyperactivity disorder (ADHD) - methylphenidate (TA13) (replaced by TA98) (withdrawn) Oct 2000 TBC
TA14 Hepatitis C - alpha interferon and ribavirin (TA14) (replaced by TA75) (withdrawn) Oct 2000 TBC
TA15 Flu - zanamivir (TA15) (replaced by TA58) (withdrawn) Nov 2000 TBC
TA16 Knee joints (defective) - autologous cartilage transplantation (TA16) (replaced by TA89) (withdrawn) Dec 2000 TBC
TA17 Colorectal cancer - laparoscopic surgery (TA17) (replaced by TA105) Dec 2000 TBC
TA18 Hernia (inguinal) - laparoscopic surgery (TA18) (replaced by TA83) (withdrawn) Jan 2001 TBC
TA19 Alzheimer's disease - donepezil, rivastigmine and galantamine (TA19) (replaced by TA111) (withdrawn) Jan 2001 TBC
TA20 Motor neurone disease - riluzole (TA20) Jan 2001 TBC

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.